Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Congress lends total effort to completing bioterror law

This article was originally published in Clinica

Executive Summary

Congress returns from its week-long Thanksgiving vacation this week facing the self-imposed deadline of enacting a bioterrorism preparedness bill before year's end. The leading bill in the US Senate was introduced by Senators Edward Kennedy and Bill Frist just before lawmakers left for their break. It would provide $3.2 billion in fiscal year 2002 for emergency funding - about double what the White House has proposed - and "such sums" as necessary for the following four years.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074160

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel